Venclexta is a brand-name oral tablet prescribed for certain kinds of cancer. Venclexta contains the active ingredient venetoclax.
Venclexta is FDA approved to treat:
- chronic lymphocytic leukemia (CLL) in adults
- small lymphocytic lymphoma (SLL) in adults
- newly diagnosed acute myeloid leukemia (AML) in adults ages 75 years or older, or in adults who can’t have standard chemotherapy
For details, see the “Venclexta for acute myeloid leukemia (AML)” and “Venclexta other uses” sections below.
Drug details
You’ll find key information about Venclexta below.
- Drug class: B-cell lymphoma-2 (BCL-2) inhibitor, which is a type of targeted therapy
- Drug form: oral tablet
- Generic available? no
- Prescription required? yes
- Controlled substance? no
- Year of FDA approval: 2016
Venclexta is available only as a brand-name medication. It’s not currently available in generic form.
A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics usually cost less than brand-name drugs.
Venclexta can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Venclexta. These lists do not include all possible side effects.
For more information on the possible side effects of Venclexta, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be concerning or bothersome.
Note: The Food and Drug Administration (FDA) tracks side effects of drugs they have approved. If you would like to report to the FDA a side effect you’ve had with Venclexta, you can do so through MedWatch.
Mild side effects
The mild side effects of Venclexta that are more common can include:
- diarrhea
- nausea and vomiting
- constipation
- abdominal pain
- cough
- fatigue
- upper respiratory infection, such as the common cold
- muscle, joint, or bone pain
- edema (fluid retention that causes swelling of your legs, feet, arms, or hands)
- fever
- rash
- dizziness
Most of these side effects may go away within a few days or a couple of weeks. But if they become more severe or don’t go away, talk with your doctor or pharmacist.
Serious side effects
Serious side effects from Venclexta are also possible. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.
Serious side effects include:
- fetal death or severe congenital anomalies (commonly known as birth defects) if a pregnant person takes Venclexta
- infections, such as pneumonia (lung infection) or sepsis (blood infection)
Other serious side effects are explained below in “Side effect details.” These include:
- tumor lysis syndrome (TLS)
- blood disorders, such as neutropenia (low white blood cell count), anemia (low red blood cell count), or thrombocytopenia (low platelet count)
Side effect details
You may wonder how often certain side effects occur with this drug. Here’s some detail on several of the side effects this drug may cause.
Tumor lysis syndrome
Tumor lysis syndrome (TLS) is a side effect that can happen when cancer cells break down very quickly. When the cells break down, they release various substances into your blood. These include uric acid, potassium, calcium, and phosphate. Your kidneys have to quickly remove these substances to prevent them from building up in your blood. TLS can sometimes lead to kidney failure and the need for dialysis. It can quickly become life threatening.
To lower your risk of developing TLS, you should drink plenty of water during your Venclexta treatment. Drink six to eight glasses (1.5 L to 2 L) of water per day, starting 2 days before your first dose of Venclexta. Some people may also need to be given fluids directly into a vein. Your doctor may also ask you to take a medication called allopurinol (Lopurin, Zyloprim) to help prevent uric acid buildup in your body.
You’ll have frequent blood tests to check for signs of TLS during treatment. Tell your doctor right away if you get any symptoms of TLS, which may include:
- fever
- chills
- nausea
- vomiting
- confusion
- shortness of breath
- dark or cloudy urine
- muscle or joint pain
- feeling weak or tired
- irregular heartbeat
- seizures
If you get TLS, your doctor may lower your dose of Venclexta or ask you to stop taking it temporarily until the problem is resolved.
Blood disorders
With CLL, SLL, and AML, people often have low numbers of healthy blood cells. Taking Venclexta can also cause problems with your blood cell counts.
Neutropenia (low white blood cell count) is the most common blood disorder that can happen with Venclexta. It raises your risk of getting infections, which can sometimes be serious or even fatal.
In clinical studies, respiratory tract infections, such as colds and pneumonia, were the most common type of infection reported in people who took Venclexta. Other types of infections reported included urinary tract infections and sepsis (blood infection).
Anemia (low red blood cell count) and thrombocytopenia (low platelet count) are also common with Venclexta. How often they occur may depend on what condition Venclexta is used to treat and what other drugs are taken with Venclexta.
While you’re taking Venclexta you’ll have frequent blood tests to check your blood cells. If you have problems with your blood cells, your doctor may lower your dose of Venclexta or ask you to stop taking it temporarily until the problem is resolved.
See your doctor right away if you get any symptoms of problems with your blood cells during treatment. These can include:
- fever
- chills
- shortness of breath
- any signs of infections, such as cough, sore throat, or pain when urinating
- bruising easily
- unusual bleeding, or taking longer than usual to stop bleeding
- fatigue
- pale-looking skin or gums
Nausea
Venclexta may cause nausea. Nausea can also be a symptom of TLS (see the “Tumor lysis syndrome” section above).
Talk with your doctor about ways to manage nausea while taking Venclexta. Your doctor may suggest medication, but other tips for managing nausea include:
- eating small amounts throughout the day, instead of having three main meals
- avoiding greasy or fatty foods
- sipping fluids often, instead of drinking a lot at once
ALLERGIC REACTIONFor some people, Venclexta can cause an allergic reaction. But it’s not clear whether this side effect occurred in the drug’s studies.
In general, symptoms of allergic reaction can be mild or serious. You can learn more about possible symptoms in this article.
Ways to manage
For mild allergic reaction symptoms, such as a mild rash, call your doctor right away. They may recommend treatments to help manage your symptoms. They’ll also let you know whether you should keep taking the medication.
For severe allergic reaction symptoms, such as swelling or trouble breathing, call 911 or your local emergency number right away. These symptoms require immediate medical care because they can become life threatening. If you’ve had a serious allergic reaction to Venclexta, your doctor may recommend taking a different medication instead.
The Food and Drug Administration (FDA) approves prescription drugs such as Venclexta to treat certain conditions. Venclexta may also be prescribed off-label for other conditions. Off-label use is when a drug that’s approved to treat one condition is prescribed to treat a different condition.
Venclexta is FDA approved to treat newly diagnosed AML. It’s approved for use in adults who are ages 75 years or older, and in adults (of any age) who can’t have standard chemotherapy.
Venclexta is used with either azacitidine (Vidaza), decitabine (Dacogen), or low dose cytarabine to treat AML. These are all chemotherapy drugs.
AML is a cancer that affects myeloid cells. Myeloid cells are found in your bone marrow. They normally develop into red blood cells, white blood cells, and platelets. With AML, the myeloid cells develop abnormally, and form abnormal blood cells, which are called blasts or leukemia cells. Leukemia cells can’t perform the usual functions of blood cells, and they take up a lot of space in your bone marrow. This leaves your bone marrow unable to make enough healthy blood cells.
Venclexta is a targeted therapy for AML. It targets and blocks a specific protein within the cancer cells that helps them live for longer than they should.
For details about this condition, you can refer to our cancer hub.
Note: See the “Venclexta other uses” section below for information on other approved uses.
Effectiveness for AML
In two clinical studies, Venclexta was found to be effective for treating newly diagnosed AML. In some cases it helped people reach complete remission, which refers to having no signs or symptoms of cancer. Some people stayed in remission for 5 to 6 months or more.
Besides being approved to treat acute myeloid leukemia, or AML, (see the section above), Venclexta is also approved to treat two other conditions. It’s also prescribed for some off-label uses.
Venclexta for CLL or SLL
Venclexta is FDA approved to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults. CLL and SLL are cancers that affect certain white blood cells called B cells. With SLL, the cancer cells are mainly in the lymph nodes. With CLL, the cancer cells are mainly in the blood and bone marrow.
For details about these conditions, you can refer to our cancer hub.
Venclexta is a targeted therapy for CLL and SLL. It targets and blocks a specific protein within the cancer cells that helps them live for longer than they should.
Effectiveness for CLL or SLL
In clinical studies, Venclexta was found to be effective for treating CLL and SLL.
In people with CLL, Venclexta lowered the risk of the cancer getting worse or spreading compared with people who took different cancer medications. Venclexta also helped more people go into complete remission (when there are no signs or symptoms of the cancer) and maintain remission for longer after completing treatment.
When Venclexta was taken with rituximab (Rituxan) for CLL, the drug helped more people go into partial remission (cancer is much improved but still present) or complete remission with incomplete marrow recovery. This is when there are no signs or symptoms of the cancer, but healthy blood cell counts remain low. This was in comparison to people who took a chemotherapy drug called bendamustine (Treanda) plus rituximab.
In studies of people with CLL or SLL who’d already had at least one treatment for their cancer, Venclexta treatment led to some improvement in their condition for 70% to 80% of people. This may have been a partial remission, complete remission, or complete remission with incomplete bone marrow recovery.
Off-label uses for Venclexta
In addition to the uses listed above, Venclexta may be prescribed off-label. Off-label drug use is when a drug that’s approved for one use is prescribed for a different one that’s not approved.
Venclexta for multiple myeloma (MM)
Multiple myeloma is a type of cancer that affects certain white blood cells called plasma cells. Venclexta is not FDA approved to treat multiple myeloma, but doctors might prescribe it off-label for this type of cancer. This would usually be as part of a clinical study.
There have been some safety issues related to this use of Venclexta. However, studies are ongoing to determine whether the treatment is safe and effective for multiple myeloma.
Venclexta for myelodysplastic syndrome (MDS)
Myelodysplastic syndrome (MDS) refers to a group of cancers involving your blood cells and bone marrow. In some cases, MDS can progress to acute myeloid leukemia (AML). (Venclexta is approved to treat AML in adults ages 75 years or older, and in adults who can’t have standard chemotherapy.)
Venclexta is not FDA approved to treat MDS. However, researchers are investigating its use for treating this condition. The drug can be prescribed off-label for MDS, but this would usually be as part of a clinical study.
Venclexta for mantle cell lymphoma (MCL)
Mantle cell lymphoma (MCL) is a type of cancer that affects white blood cells called B lymphocytes.
Venclexta is not FDA approved to treat MCL, but doctors might prescribe it off-label to treat this type of cancer. This would usually be as part of a clinical study.
For chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), you may take Venclexta on its own, or you may take it with rituximab (Rituxan) or obinutuzumab (Gazyva). These are both targeted drugs called monoclonal antibodies. They help your body recognize and attack cancer cells.
For acute myeloid leukemia (AML), you’ll take Venclexta with either azacitidine (Vidaza), decitabine (Dacogen), or low dose cytarabine. These are all chemotherapy drugs.
The Venclexta dosage your doctor prescribes will depend on several factors. These include:
- the condition you’re taking Venclexta to treat
- your liver function
- other medications you’re taking
- any side effects you get
When you first start treatment, you’ll take a low dose that will be gradually increased. This helps lower your risk of developing a side effect called tumor lysis syndrome (TLS), which can happen when cancer cells break down very quickly.
The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your needs.
Drug forms and strengths
Venclexta comes as tablets that you take by mouth once per day. It’s available in three strengths: 10 mg, 50 mg, and 100 mg.
Dosage for AML
If you’re taking Venclexta for acute myeloid leukemia (AML), your dosage will likely be increased gradually over the first 3 days of treatment as follows:
- day 1: 100 mg
- day 2: 200 mg
- day 3: 400 mg
If you take Venclexta with azacitidine or decitabine, you’ll likely continue to take 400 mg of Venclexta once daily after day 3. Keep taking it for as long as your doctor recommends.
If you take Venclexta with low dose cytarabine, you’ll take 600 mg of Venclexta once daily starting on day 4. Keep taking it for as long as your doctor recommends.
Take your daily dose at the same time each day.
Dosage for CLL or SLL
If you’re taking Venclexta for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), your dosage will likely be increased gradually over the first 5 weeks of treatment as follows:
- week 1: 20 mg once daily
- week 2: 50 mg once daily
- week 3: 100 mg once daily
- week 4: 200 mg once daily
- week 5: 400 mg once daily
After this, you’ll likely continue to take 400 mg of Venclexta once per day for as long as your doctor recommends.
Take your daily dose at the same time each day.
What if I miss a dose?
If you forget to take a dose at your usual time, follow these instructions:
- If it’s less than 8 hours after your dose was due, take the missed dose, and then take your next dose at the usual time.
- If it’s more than 8 hours after your dose was due, skip the missed dose, and take your next dose at the usual time.
Never take a double dose to make up for a missed dose.
To help make sure you don’t miss a dose, try setting a reminder on your phone. A medication timer may be useful, too.
How long will I need to take Venclexta?
How long you take Venclexta will depend on the condition you’re taking it to treat and what other medications you’re taking.
For CLL or SLL:
- if you’re also taking obinutuzumab (Gazyva), you’ll likely take Venclexta for 1 year
- if you’re also taking rituximab (Rituxan), you’ll likely take Venclexta for 2 years
- if you’re taking Venclexta on its own, you’ll take it for as long as it continues to be safe and effective for you
For AML, you’ll take Venclexta for as long as it continues to be safe and effective for you.
Other drugs are available that can treat your condition. Some may be a better fit for you than others. If you’re interested in finding an alternative to Venclexta, talk with your doctor. They can tell you about other medications that may work well for you.
Note: Some of the drugs listed here are prescribed off-label to treat these specific conditions. Off-label use is when a drug that’s approved to treat one condition is prescribed to treat a different condition.
Alternatives for AML
Examples of other drugs that may be used to treat acute myeloid leukemia (AML) include:
- chemotherapy, such as:
- azacitidine (Vidaza)
- cladribine (Leustatin)
- cytarabine
- daunorubicin
- decitabine (Dacogen)
- etoposide
- fludarabine (Fludara)
- hydroxyurea
- idarubicin
- methotrexate
- mitoxantrone
- targeted therapies, such as:
Alternatives for CLL or SLL
Examples of other drugs that may be used to treat either chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) include:
- chemotherapy, such as:
- bendamustine (Treanda)
- chorambucil (Leukeran)
- cladribine (Leustatin)
- cyclophosphamide
- fludarabine (Fludara)
- targeted therapies, such as:
You may wonder how Venclexta compares with other medications that are prescribed for similar uses. Here we look at how Venclexta and Imbruvica are alike and different.
Ingredients
Venclexta contains the active ingredient venetoclax. Imbruvica contains the active ingredient ibrutinib. These are both targeted treatments for cancer. They work in different ways, each targeting a certain feature of the cancer cells.
Uses
Venclexta is FDA approved to treat:
- chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults
- newly diagnosed acute myeloid leukemia (AML) in adults ages 75 years or older, or in adults who can’t have standard chemotherapy
Imbruvica is FDA approved to treat:
- CLL or SLL in adults
- CLL or SLL with a 17p deletion (a particular genetic mutation in the cancer cells) in adults
- Waldenström’s macroglobulinemia (a type of non-Hodgkin’s lymphoma) in adults
- chronic graft versus host disease (when cells in your body are attacked by donor immune cells after a bone marrow or stem cell transplant) in adults, when other treatments haven’t been successful
Drug forms and administration
Venclexta comes as tablets that you take by mouth once per day. Imbruvica comes as capsules, tablets, and an oral suspension (a type of liquid mixture) that you take by mouth once per day.
Side effects and risks
Venclexta and Imbruvica have some similar side effects and others that differ. Below are examples of these side effects.
Mild side effects
These lists contain examples of mild side effects that can occur with Imbruvica or with both drugs (when taken individually).
- Can occur with Imbruvica:
- bruising
- muscle spasms
- Can occur with both Venclexta and Imbruvica:
- diarrhea
- nausea and vomiting
- constipation
- abdominal pain
- cough
- upper respiratory infection, such as the common cold
- fatigue
- fever
- muscle, joint, or bone pain
- edema (fluid retention that causes swelling of your legs, feet, arms, or hands)
- dizziness
- rash
Serious side effects
These lists contain examples of serious side effects that can occur with Venclexta, with Imbruvica, or with both drugs (when taken individually).
- Can occur with Venclexta:
- fetal death or severe congenital anomalies (commonly known as birth defects) if a pregnant person takes Venclexta
- Can occur with Imbruvica:
- bleeding problems
- heart rhythm problems
- high blood pressure
- new cancers
- Can occur with both Venclexta and Imbruvica:
- tumor lysis syndrome (TLS)
- blood disorders, such as neutropenia (low white blood cell count), anemia (low red blood cell count), or thrombocytopenia
- infections, such as pneumonia or sepsis (blood infection)
Effectiveness
Venclexta and Imbruvica haven’t been directly compared in clinical studies. However, studies have found both Venclexta and Imbruvica to be effective for treating CLL and SLL.
Costs
Venclexta and Imbruvica are both brand-name drugs. There are currently no generic forms of either drug. Brand-name medications usually cost more than generics.
Venclexta tends to be significantly less expensive than Imbruvica. The actual price you’ll pay for either drug depends on your insurance plan, your location, and the pharmacy you use.
Venclexta and Daurismo are prescribed for similar uses. Below are details of how these drugs are alike and different.
Ingredients
Venclexta contains the active drug venetoclax. Daurismo contains the active drug glasdegib. They are both targeted treatments for cancer. They work in different ways, each targeting a certain feature of the cancer cells.
Uses
Venclexta and Daurismo are both FDA approved to treat:
- newly diagnosed acute myeloid leukemia (AML) in adults ages 75 years or older, or in adults who can’t have standard chemotherapy
To treat AML, Venclexta is used with either azacitidine (Vidaza), decitabine (Dacogen), or low dose cytarabine. These are all chemotherapy drugs. Daurismo is used with low dose cytarabine.
Venclexta is also FDA approved to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults.
Drug forms and administration
Venclexta and Daurismo both come as tablets that you take by mouth once per day.
Side effects and risks
Venclexta and Daurismo can cause some similar side effects and others that vary. Below are examples of these side effects.
Mild side effects
These lists contain examples of mild side effects that can occur with Venclexta, with Daurismo, or with both drugs (when taken individually).
- Can occur with Venclexta:
- diarrhea
- cough
- upper respiratory infection, such as the common cold
- joint pain
- vomiting
- abdominal pain
- fever
- dizziness
- Can occur with Daurismo:
- bleeding
- reduced appetite
- change in the way things taste
- sore mouth or throat
- Can occur with both Venclexta and Daurismo:
Serious side effects
These lists contain examples of serious side effects that can occur with Venclexta, with Daurismo, or with both drugs (when taken individually).
- Can occur with Venclexta:
- tumor lysis syndrome (TLS)
- infections, such as pneumonia or sepsis (blood infection)
- Can occur with Daurismo:
- abnormal heart rhythm
- Can occur with both Venclexta and Daurismo:
- blood disorders, such as neutropenia (low white blood cell count), anemia (low red blood cell count), or thrombocytopenia (low platelet count)
- fetal death or severe congenital anomalies (commonly known as birth defects) if a pregnant person takes either of these drugs*
* Daurismo has a boxed warning for this side effect. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).
Effectiveness
Venclexta and Daurismo haven’t been directly compared in clinical studies. However, studies have found both Venclexta and Daurismo to be effective for treating newly diagnosed AML in adults.
Costs
Venclexta and Daurismo are both brand-name drugs. There are currently no generic forms of either drug. Brand-name medications usually cost more than generics.
Venclexta is significantly less expensive than Daurismo. The actual price you’ll pay for either drug depends on your insurance plan, your location, and the pharmacy you use.
There are no known interactions between Venclexta and alcohol. However, if Venclexta causes nausea or diarrhea, drinking alcohol could make these side effects worse.
If you drink alcohol, talk with your doctor about how much is safe for you to drink while you take Venclexta.
Venclexta can interact with several other medications. It can also interact with certain supplements as well as certain foods.
Different interactions can cause different effects. For instance, some interactions can interfere with how well a drug works. Other interactions can increase side effects or make them more severe.
Venclexta and other medications
Below is a list of medications that can interact with Venclexta. This list does not contain all drugs that may interact with Venclexta.
Before taking Venclexta, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.
If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.
Venclexta and certain antibiotic drugs
Taking Venclexta with certain antibiotics can cause Venclexta to build up in your body. This can raise your risk of side effects from Venclexta.
Examples of antibiotics that can make Venclexta build up in your body include:
- ciprofloxacin (Cipro)
- clarithromycin
- erythromycin (Eryc, Ery-Tab)
- telithromycin (Ketek)
These antibiotics should usually be avoided while you take Venclexta, especially while your dosage is being increased. If you need to take one of these drugs, your doctor will temporarily lower your Venclexta dosage.
Taking Venclexta with certain other antibiotics can lower the amount of Venclexta in your body. This could make it less effective. Therefore, these drugs should not be taken with Venclexta.
Examples of antibiotics that can make Venclexta less effective include:
- rifabutin (Mycobutin)
- rifampin (Rifadin)
- rifapentine (Priftin)
Venclexta and certain antifungal drugs
Taking Venclexta with certain antifungal drugs can cause Venclexta to build up in your body. This can raise your risk of side effects from Venclexta.
Examples of antifungals that can make Venclexta build up in your body include:
- fluconazole (Diflucan)
- itraconazole (Sporanox, Onmel, Tolsura)
- ketoconazole
- posaconazole (Noxafil)
- voriconazole (Vfend)
These antifungals should usually be avoided while you take Venclexta, especially while your dosage is being increased. If you need to take one of these drugs, your doctor will temporarily lower your Venclexta dosage.
Venclexta and certain drugs for HIV
Taking Venclexta with certain HIV treatments can cause Venclexta to build up in your body. This can raise your risk for getting side effects from Venclexta.
Examples of HIV drugs that can cause Venclexta to build up in your body include:
- atazanavir (Reyataz)
- cobicistat (Tybost)
- darunavir (Prezista)
- fosamprenavir (Lexiva)
- indinavir (Crixivan)
- lopinavir/ritonavir (Kaletra)
- nelfinavir (Viracept)
- ritonavir (Norvir)
- saquinavir (Invirase)
These HIV drugs should usually be avoided while you take Venclexta, especially while your dosage is being increased. If you need to take one of these drugs, your doctor will temporarily lower your Venclexta dosage.
Venclexta and certain seizure medications
Taking Venclexta with certain seizure medications can lower the amount of Venclexta in your body. This could make it less effective. Therefore, you shouldn’t take these drugs with Venclexta.
Examples of seizure medications that can make Venclexta less effective include:
- carbamazepine (Carbatrol, Equetro, Tegretol)
- fosphenytoin (Cerebyx)
- oxcarbazepine (Trileptal)
- phenobarbital
- phenytoin (Dilantin, Phenytek)
- primidone (Mysoline)
Venclexta and warfarin
Taking warfarin (Jantoven) with Venclexta can increase the blood thinning effect of warfarin. This could raise your risk for bleeding. If you take Venclexta with warfarin, your blood clotting time should be checked regularly, especially after any increases in your Venclexta dosage.
Venclexta and digoxin
Taking digoxin (Lanoxin) with Venclexta can increase the amount of digoxin in your body. This can raise your risk for side effects with digoxin. If you need to take Venclexta with digoxin, take your digoxin dose at least 6 hours before your Venclexta dose.
Venclexta and live vaccines
Getting a live vaccine while taking Venclexta can cause serious infections.
Live vaccines contain weakened forms of viruses or bacteria. They don’t cause infections in people with healthy immune systems. However, they could cause infections if your immune system activity is reduced due to cancer or from taking Venclexta.
While you’re taking Venclexta, you shouldn’t get live vaccines such as:
- chickenpox
- measles, mumps, and rubella (MMR)
- the nasal spray form of the flu vaccine
- tuberculosis
- yellow fever
It’s safe to get inactive (not live) vaccines, such as the flu shot, while you’re taking Venclexta. However, it’s possible that the vaccines might be less effective than usual.
Venclexta and herbs and supplements
You should not take St. John’s wort (Hypericum perforatum) while you’re taking Venclexta. St. John’s wort can lower the amount of Venclexta in your body and could make it less effective.
It’s possible that certain other herbs and supplements could affect the amount of Venclexta in your body. Examples of these supplements include:
However, it’s not known for sure if any of these herbs and supplements (besides St. John’s wort) interact with Venclexta. Check with your doctor or pharmacist before taking any herbs or supplements while taking Venclexta.
Venclexta and foods
While taking Venclexta, don’t drink grapefruit juice or eat grapefruit. Also, don’t eat Seville oranges or starfruit. These fruits can make Venclexta build up in your body, which can raise your risk for side effects.
As with all medications, the cost of Venclexta can vary. The actual price you’ll pay depends on your insurance plan, your location, and the pharmacy you use.
It’s important to note that you’ll have to get Venclexta at a specialty pharmacy. These are pharmacies authorized to carry specialty medications (drugs that are complex, have high prices, are difficult to take, or have special dosage or storage requirements).
Your insurance plan may require you to get prior authorization before approving coverage for Venclexta. This means that your doctor and insurance company will need to communicate about your prescription before the insurance company will cover the drug. The insurance company will review the request and let you and your doctor know if your plan will cover Venclexta.
If you’re not sure if you’ll need to get prior authorization for Venclexta, contact your insurance company.
Financial and insurance assistance
If you need financial support to pay for Venclexta, or if you need help understanding your insurance coverage, help is available.
Genentech, Inc., the manufacturer of Venclexta, offers programs that may help lower the cost of your treatment. You can learn more about these programs on the manufacturer’s website.
You should take Venclexta according to your doctor’s or healthcare professional’s instructions.
When to take
You can take your Venclexta dose at any time of day, but always take it at about the same time.
To help make sure you don’t miss a dose, try setting a reminder on your phone. A medication timer may be useful, too.
Taking Venclexta with food
Take Venclexta with a meal and drink of water.
You should drink plenty of water during Venclexta treatment, to lower your risk of developing a side effect called tumor lysis syndrome (TLS). See “Common questions about Venclexta” below for details.
Can Venclexta be crushed, split, or chewed?
No. You should swallow Venclexta tablets whole. Don’t split, crush, or chew them.
Venclexta is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). These are cancers that affect your blood cells.
What happens in CLL, SLL, and AML
CLL and SLL affect white blood cells called B lymphocytes. These cells usually help your body fight infections. With CLL and SLL, abnormal B lymphocytes that don’t work properly develop in your bone marrow.
When a person develops CLL, the cancer cells stay mainly in the bone marrow and blood. When a person develops SLL, the cancer cells move mainly to the lymph nodes.
AML affects myeloid cells found in the bone marrow. Myeloid cells usually develop into red blood cells, white blood cells, and platelets. With AML, the myeloid cells develop into abnormal blood cells that don’t work properly.
With all three diseases, the cancer cells take up a lot of space in your bone marrow. This prevents your bone marrow from making enough healthy blood cells. The cancer cells multiply faster and survive longer than healthy blood cells.
What Venclexta does
Venclexta is a targeted therapy for CLL, SLL, and AML. It’s a type of drug called a BCL-2 inhibitor.
BCL-2 is a protein that’s involved in regulating when cells in the body die. High levels of this protein are found in CLL, SLL, and AML cells. It helps these cells live longer than they should. It may also help the cells be resistant to chemotherapy.
Venclexta attaches to the BCL-2 protein and stops it from working. This causes the cancer cells to die.
How long does it take to work?
Venclexta starts to work within a few hours after you take your first dose. You probably won’t notice Venclexta working, unless you get symptoms of tumor lysis syndrome (TLS). (See the “Venclexta side effects” section for more information.)
You’ll have blood tests during your treatment to check that Venclexta is working for you.
In most cases, Venclexta should not be taken during pregnancy. This is because it could be harmful to a fetus.
If you can become pregnant, your doctor may have you take a pregnancy test before starting Venclexta to make sure you’re not pregnant.
Venclexta use during human pregnancy hasn’t been studied. However, the drug caused fetal harm in animal studies. Animal studies don’t always predict what will happen in humans, but Venclexta could be harmful to a fetus if taken during pregnancy.
Tell your doctor if you are pregnant or planning to become pregnant before you start treatment with Venclexta.
See your doctor right away if you get pregnant or think you could be pregnant, while taking Venclexta.
Venclexta and fertility
Venclexta may decrease male fertility (biological ability to have children). In animal studies, the drug caused decreased sperm count or no sperm count. But animal studies don’t always predict what will happen in humans.
These studies didn’t report the effects of Venclexta on fertility in females.
You can discuss Venclexta’s possible effects on fertility with your doctor before you start treatment. They can provide details and recommend whether Venclexta is the best treatment option for your type of cancer.
Note: Sex and gender exist on spectrums. Use of the terms “female” and “male” in this article refers to sex assigned at birth.
Venclexta could be harmful to a fetus if taken during pregnancy. If you’re sexually active and you can become pregnant, it’s recommended that you use birth control while taking Venclexta and for at least 30 days after stopping treatment. Talk with your doctor about your birth control needs while you’re taking Venclexta.
It’s recommended to avoid breastfeeding while taking Venclexta and for at least 1 week after you stop Venclexta treatment.
It’s not known if Venclexta passes into human breast milk. In animal studies, the drug did pass into milk when given to lactating animals. Animal studies don’t always predict what will happen in humans. But if Venclexta does pass into human breast milk, it could have adverse effects on a child who is breastfed.
If you’re currently breastfeeding, talk with your doctor about the best way to feed your child while you take Venclexta.
Here are answers to some frequently asked questions about Venclexta.
Why do I need to drink so much water during Venclexta treatment?
You need to drink plenty of water while taking Venclexta to lower your risk of developing a side effect called tumor lysis syndrome (TLS).
Drinking water is especially important in the 2 days before you start Venclexta, on the first day you take it, and on each day your dose is increased. You should aim to drink six to eight glasses of water (1.5 L to 2 L) each day during your treatment.
TLS can happen when large numbers of cancer cells break down very quickly. When the cells break down, they release chemicals such as uric acid, potassium, calcium, and phosphate into your blood. Your kidneys have to quickly remove these chemicals to avoid a buildup in your blood. Drinking lots of water helps your kidneys work to remove these chemicals from your blood.
Can I get a flu shot while I’m taking Venclexta?
Yes, you can. Getting the vaccine is the best way to protect yourself from getting the flu. Cancers like leukemia and lymphoma can reduce your immune system activity (sometimes referred to as “weakening” your immune system), making it harder to fight infections like the flu. Flu can be much more serious if you have a weak immune system.
You should get the injected form of the flu vaccine (the flu shot) while you’re taking Venclexta. This contains flu virus that has been inactivated, which means it can’t cause the flu.
You shouldn’t get the nasal spray form of the flu vaccine while you’re taking Venclexta. The nasal vaccine contains live strains of the flu virus. The virus has been weakened, and it can’t cause flu in healthy people. However, it’s possible that it could cause flu if you have reduced immune system activity.
Is Venclexta safe to use over a long period of time?
Yes. If you have SLL or CLL, you may take Venclexta for up to 1 year or 2 years. If you have AML, you can take Venclexta for as long as you and your doctor determine it’s safe for you to take. Talk with your doctor about how long you should take Venclexta.
Is Venclexta a chemotherapy drug?
No, Venclexta is not chemotherapy. Chemotherapy works by attacking all cells that are multiplying rapidly. It can affect healthy cells along with cancer cells. This is why chemotherapy drugs can have many side effects.
Venclexta is a targeted therapy for cancer. It works on specific proteins inside the cancer cells that make the cells survive longer than they should. It can still affect some healthy cells and can cause some serious side effects. However, targeted therapies like Venclexta tend to have fewer side effects than chemotherapy.
Why do I need to have blood tests so often during Venclexta treatment?
You’ll have frequent blood tests so your doctor can check for possible side effects of Venclexta. These include TLS and reduced blood cell counts. Getting blood tests done often allows your doctor to quickly treat any problems that develop. If needed, they can also lower your dose or temporarily stop treatment.
If you have questions about what blood tests to expect, be sure to ask your doctor for details.
Before taking Venclexta, talk with your doctor about your health history. Venclexta may not be right for you if you have certain medical conditions or other factors affecting your health. Be sure to talk with your doctor if any of the following apply to you:
- liver problems
- high levels of potassium, calcium, phosphorous, or uric acid in your blood
- kidney problems
- previous allergic reaction to this or a similar drug
- pregnancy
- breastfeeding
Note: For more information about the potential negative effects of Venclexta, see the “Venclexta side effects” section above.
Taking more than the recommended dosage of Venclexta can lead to serious side effects.
Do not use more Venclexta than your doctor recommends.
What to do in case of overdose
If you think you’ve taken too much of this drug, call your doctor. You can also call America’s Poison Centers at 800-222-1222 or use its online tool. But if your symptoms are severe, call 911 or go to the nearest emergency room right away.
When you get Venclexta from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically 1 year from the date they dispensed the medication.
The expiration date helps guarantee that the medication remains effective during this time. The
Storage
How long a medication remains good can depend on many factors, including how and where you store the medication.
Store Venclexta tablets at or below 86°F (30°C) in a tightly sealed container away from light. Avoid storing this medication in areas where it could get damp or wet, such as bathrooms.
Disposal
If you no longer need to take Venclexta and have leftover medication, it’s important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.
The
Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.